Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?

Igor B Resnick1, Diana Averbuch, Memet Aker

  • 1Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Hebrew University, Hadassah Medical School, Jerusalem, Israel.

Insights

Pneumocystis pneumonia (PCP) may be contagious in hematopoietic stem cell transplant (HSCT) recipients. This risk is heightened in infants and young children, necessitating careful avoidance strategies to prevent infection transmission.

Area of Science:

  • Pediatric Hematology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Neonatal acute leukemia presents a critical challenge requiring aggressive treatment like hematopoietic stem cell transplantation (HSCT).
  • HSCT recipients are profoundly immunocompromised, increasing susceptibility to opportunistic infections.
  • Pneumocystis jiroveci pneumonia (PCP) is a significant threat in immunocompromised populations, particularly after transplantation.

Observation:

  • Identical twins undergoing HSCT for neonatal acute leukemia were hospitalized together.
  • The first twin developed respiratory symptoms, followed by the second twin developing Pneumocystis jiroveci pneumonia (PCP) two weeks later.
  • Both twins were housed in the same room throughout their hospitalization.

Findings:

  • The sequential development of PCP in twins treated in close proximity suggests potential contagion.
  • This case highlights the possibility of person-to-person transmission of Pneumocystis jiroveci in a highly vulnerable HSCT recipient population.
  • The timing of PCP onset in both twins indicates a possible incubation period and transmission event.

Implications:

  • PCP may be transmissible between hematopoietic stem cell transplant recipients, especially infants and young children.
  • Enhanced infection control measures and isolation protocols may be necessary for HSCT units, particularly for pediatric patients.
  • Further research is warranted to elucidate the transmission dynamics of Pneumocystis jiroveci in HSCT recipients to refine preventative strategies.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...